Log In
Print this Print this

Aminoacyl tRNA synthetase fragments (Tmax) (ATYR0030)

  Manage Alerts
Collapse Summary General Information
Company aTyr Pharma Inc.
DescriptionRecombinant form of a signaling peptide derived from human aminoacyl tRNA synthetases
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today